
Sign up to save your podcasts
Or


A major bankruptcy case of Purdue Pharma—the makers of Oxycontin—now sits with the Supreme Court. How did it get there, and what's at stake? Andy Dietderich, an expert in bankruptcy law and co-head of finance and restructuring at New York law firm Sullivan and Cromwell, talks with Dr. Josh Sharfstein about the case, the Sackler family's involvement, and what a SCOTUS decision could mean for future settlements.
By The Johns Hopkins Bloomberg School of Public Health4.7
624624 ratings
A major bankruptcy case of Purdue Pharma—the makers of Oxycontin—now sits with the Supreme Court. How did it get there, and what's at stake? Andy Dietderich, an expert in bankruptcy law and co-head of finance and restructuring at New York law firm Sullivan and Cromwell, talks with Dr. Josh Sharfstein about the case, the Sackler family's involvement, and what a SCOTUS decision could mean for future settlements.

21,937 Listeners

38,538 Listeners

43,506 Listeners

4,014 Listeners

40 Listeners

5 Listeners

26 Listeners

6,446 Listeners

4 Listeners

112,990 Listeners

56,848 Listeners

496 Listeners

9 Listeners

3,745 Listeners

45 Listeners

16,491 Listeners

16 Listeners

4,846 Listeners

3 Listeners

6,578 Listeners

25 Listeners

8,219 Listeners

6,436 Listeners

3,361 Listeners